Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)-Reference-Cited by-同舟云学术

Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)

Published:2019-01-25 Issue:3 Volume:19 Page:894-906
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Leibler Claire¹²,Matignon Marie¹²,Moktefi Anissa²³,Samson Chloé²,Zarour Anissa⁴,Malard Stéphanie⁵,Boutin Emmanuelle⁴⁶,Pilon Caroline²,Salomon Laurent⁷,Natella Pierre‐André⁴,Durrbach Antoine⁶,Robert Thomas⁸,Canoui‐Poitrine Florence⁴⁹,Grimbert Philippe¹²¹⁰

Affiliation:

1. Assistance Publique‐Hôpitaux de Paris Nephrology and Renal Transplantation Department Institut Francilien de Recherche en Néphrologie et Transplantation Groupe Hospitalier Henri‐Mondor/Albert‐Chenevier Créteil France

2. Université Paris‐Est‐Créteil Département Hospitalo‐Universitaire Virus‐Immunité‐Cancer Institut Mondor de Recherche Biomédicale Créteil France

3. Assistance Publique‐Hôpitaux de Paris Pathology Department Groupe Hospitalier Henri‐Mondor/Albert‐Chenevier Créteil France

4. Assistance Publique‐Hôpitaux de Paris Public Health Department/Clinical Research Unit (URC‐Mondor) Groupe Hospitalier Henri‐Mondor/Albert Chenevier Créteil France

5. Assistance Publique‐Hôpitaux de Paris Laboratoire Régional d’ Histocompatibilité Hôpital Saint Louis Paris France

6. Assistance Publique‐Hôpitaux de Paris Nephrology and Renal Transplantation Department Institut Francilien de Recherche en Néphrologie et Transplantation Hôpital Bicêtre Le Kremlin‐Bicêtre France

7. Assistance Publique‐Hôpitaux de Paris Urology Department Groupe Hospitalier Henri‐Mondor/Albert Chenevier Créteil France

8. Department of Nephrology, Transplantation and Emergency Assistance Publique‐Hôpitaux de Paris Hôpital Tenon Paris France

9. Département Hospitalo‐Universitaire A‐TVB Institut Mondor de Recherche Biomédicale ‐ EA 7376 Clinical Epidemiology and Ageing Unit Université Paris‐Est‐Créteil Créteil France

10. Assistance Publique‐Hôpitaux de Paris CIC‐BT 504 Créteil France

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15229

Reference28 articles.

1. Chronic alloantibody mediated rejection

2. Antibody-Mediated Rejection Due to Preexisting versusDe NovoDonor-Specific Antibodies in Kidney Allograft Recipients

3. Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study

4. Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation

5. Desensitization: Overcoming the Immunologic Barriers to Transplantation

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation;Kidney International Reports;2024-08

2. Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant Recipients;Clinical Journal of the American Society of Nephrology;2024-02-22

3. Translating B cell immunology to the treatment of antibody-mediated allograft rejection;Nature Reviews Nephrology;2024-01-02

4. Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future;Kidney International Reports;2023-12

5. The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice;Transplant International;2023-07-25